Downloads
News & Downloads
Download | Title *please sign up for Newsletter click here | click |
Newsletter | Prevalence Impact on P&R Decison? | |
Newsletter | Societal Perspective A benefit dilution effect? | |
Newsletter | Pricing Models (MEAs) Curse or Blessing | |
Newsletter | Swiss Cell-& Gene Different P&R processess for CGTs in Switzerland | |
Newsletter | Innovative Funding How Installment Payment & Amortization affect Budget Impact | |
Newsletter | Cell & Gene Therapy - Budget Impact Linkedin Newsletter Market Access COMPASS | |
Study-Report | Swiss Payer Study Proposed solutions for the handling of cost-intensive medicines. This study was commissioned by curafutura – The Innovative Health Insurers. | |
Newsletter | Precison Medicine - Concept & Reimbursement | * |
Newsletter | Multi Option Reimbursement | * |
Brochure | Swiss Triennial Revison | * |
Newsletter | Value Frameworks Newsletter 6, Dec 16, EN | * |
Newsletter | Disinvestment Newsletter 5, June 16, EN | * |
Newsletter | It's the economy - only? Newsletter 4, Oct 15, EN | * |
Newsletter | Decison Makers - why do they negotiate? Newsletter 3, Feb 15, EN | * |
Newsletter | Benefit categories or score? Newsletter 2, Oct 14, EN | |
Newsletter | Benefit categories or score? Newsletter 2, Oct 14, DE | |
Newsletter | Link between benefit and price? Newsletter 1, Feb 14, DE | |
Swiss Law | Swiss Law for P&R, German | |
Company Flyer | pharmaLevers GmbH: Description of key services | |
Position Paper | Market Access: Just a new buzzword or a fundamental change in doing business? | |
Position Paper | Pricing & Reimbursement: Does Pricing and Reimbursement still belong together? | |
Position Paper | Value based selling: From promotion to evidence a new paradigm of detailing? |